Search research articles
Contact Us
Filters
Showing results (11-20 of 142) with videos related to
Page
of 15
Sort By:
American Heart Journal
|
May 1, 1988
ACE inhibition for the failing heart: experience with captopril
D P Faxon
Hospital Practice (Office Ed.)
|
March 30, 1987
Current status of coronary angioplasty
D P Faxon
Postgraduate Medicine
|
December 31, 1997
Thrombolytic therapy versus primary angioplasty. Which offers the best outcome after myocardial infarction?
D P Faxon
Journal of the American College of Cardiology
|
February 1, 1995
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group
D P Faxon
Hypertension (Dallas, Tex. : 1979)
|
September 18, 1998
AHA journals lead with definitive new online site
D P Faxon
Circulation
|
September 16, 1998
AHA journals lead with definitive new online site
D P Faxon
The Keio Journal of Medicine
|
March 1, 1989
The impact of interventional techniques on the practice of cardiology
D P Faxon
The Journal of Invasive Cardiology
|
March 24, 2000
The ARTISTIC and ARREST trials
A Durairaj, D P Faxon
Current Problems in Cardiology
|
May 1, 1994
Current status of percutaneous transluminal coronary angioplasty
A Mehra, D P Faxon
International Journal of Cardiology
|
June 1, 1983
A normal coronary angiogram: is it therapeutic?
D P Faxon, C McCabe
Page
of 15
Search research articles
Search
Showing results (11-20 of 142) with videos related to
Sort By:
Page
of 15
American Heart Journal
|
May 1, 1988
ACE inhibition for the failing heart: experience with captopril
D P Faxon
Hospital Practice (Office Ed.)
|
March 30, 1987
Current status of coronary angioplasty
D P Faxon
Postgraduate Medicine
|
December 31, 1997
Thrombolytic therapy versus primary angioplasty. Which offers the best outcome after myocardial infarction?
D P Faxon
Journal of the American College of Cardiology
|
February 1, 1995
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group
D P Faxon
Hypertension (Dallas, Tex. : 1979)
|
September 18, 1998
AHA journals lead with definitive new online site
D P Faxon
Circulation
|
September 16, 1998
AHA journals lead with definitive new online site
D P Faxon
The Keio Journal of Medicine
|
March 1, 1989
The impact of interventional techniques on the practice of cardiology
D P Faxon
The Journal of Invasive Cardiology
|
March 24, 2000
The ARTISTIC and ARREST trials
A Durairaj, D P Faxon
Current Problems in Cardiology
|
May 1, 1994
Current status of percutaneous transluminal coronary angioplasty
A Mehra, D P Faxon
International Journal of Cardiology
|
June 1, 1983
A normal coronary angiogram: is it therapeutic?
D P Faxon, C McCabe
Page
of 15